| Trial Identifier: | D6014C00005 |
| Sponsor: | AstraZeneca |
| Collaborator: |
Quintiles, Inc.
|
| NCTID:: | NCT03315091 |
| Start Date: | September 2017 |
| Primary Completion Date: | April 2018 |
| Study Completion Date: | April 2018 |
| Condition: | Cancer - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Translation | |
| English Translation | |
| Dutch Translation | |
| French Translation |
| Country | Location |
|---|---|
| France | Bordeaux Cedex, France, 33075 |
| France | Saint Herblain, France, 44805 |
| Netherlands | Amsterdam, Netherlands, 1066 CX |
| Netherlands | Amsterdam, Netherlands, 1081 HV |
| Netherlands | Maastricht, Netherlands, 6229 HX |
| United Kingdom | Glasgow, United Kingdom, G12 0YN |
| United Kingdom | Manchester, United Kingdom, M20 4BX |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company